<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We reviewed retrospectively the charts of 36 patients (72 eyes) with <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease </plain></SENT>
<SENT sid="1" pm="."><plain>The visual acuities in 21 patients receiving <z:chebi fb="0" ids="23359">colchicine</z:chebi> (group A) gradually decreased with time </plain></SENT>
<SENT sid="2" pm="."><plain>The visual acuities in 9 patients receiving <z:chebi fb="0" ids="23359">colchicine</z:chebi> and systemic <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> (group B) gradually decreased after the <z:hpo ids='HP_0003674'>onset</z:hpo> of the disease and were significantly worse than those in group A 10 and 15 years after <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The visual acuities in 6 patients receiving <z:chebi fb="0" ids="23359">colchicine</z:chebi> and cyclosporin (group C) gradually decreased, and their visual acuity scores were similar to those in group A </plain></SENT>
</text></document>